These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8291442)

  • 1. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease.
    Fukuda T; Tanaka J; Watabe K; Numoto RT; Minamitani M
    Acta Pathol Jpn; 1993 Oct; 43(10):545-51. PubMed ID: 8291442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and dementia with neuronal inclusions in the cerebral cortex: Lewy bodies or Pick bodies.
    Tiller-Borcich JK; Forno LS
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):526-35. PubMed ID: 2845001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.
    Lennox G; Lowe J; Morrell K; Landon M; Mayer RJ
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):67-71. PubMed ID: 2540286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenile dementia with Alzheimer-, Pick- and Lewy-body changes.
    Kosaka K; Oyanagi S; Matsushita M; Hori A
    Acta Neuropathol; 1976 Nov; 36(3):221-33. PubMed ID: 188300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies.
    Mizutani T; Inose T; Nakajima S; Kakimi S; Uchigata M; Ikeda K; Gambetti P; Takasu T
    Acta Neuropathol; 1998 Jan; 95(1):15-27. PubMed ID: 9452818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.
    Dickson DW; Schmidt ML; Lee VM; Zhao ML; Yen SH; Trojanowski JQ
    Acta Neuropathol; 1994; 87(3):269-76. PubMed ID: 7912027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.
    Galloway PG; Bergeron C; Perry G
    Neurosci Lett; 1989 May; 100(1-3):6-10. PubMed ID: 2548130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neuropathological correlates of Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5.
    Brion JP; Couck AM
    Am J Pathol; 1995 Nov; 147(5):1465-76. PubMed ID: 7485409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal inclusions of Parkinson's disease.
    Gibb WR; Scott T; Lees AJ
    Mov Disord; 1991; 6(1):2-11. PubMed ID: 1848677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. A case report.
    Ikeda K; Ikeda S; Yoshimura T; Kato H; Namba M
    Acta Neuropathol; 1978 Feb; 41(2):165-8. PubMed ID: 205083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease.
    Kurashige T; Takahashi T; Yamazaki Y; Hiji M; Izumi Y; Yamawaki T; Matsumoto M
    Neuropathology; 2013 Jun; 33(3):237-45. PubMed ID: 22989140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system.
    Wakabayashi K; Takahashi H; Ohama E; Ikuta F
    Acta Neuropathol; 1990; 79(6):581-3. PubMed ID: 1972853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.
    Kuzuhara S; Mori H; Izumiyama N; Yoshimura M; Ihara Y
    Acta Neuropathol; 1988; 75(4):345-53. PubMed ID: 3364159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
    Kawamoto Y; Ito H; Ihara M; Takahashi R
    Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewy bodies of Parkinson's disease. Immune electron microscopic demonstration of neurofilament antigens in constituent filaments.
    Pappolla MA
    Arch Pathol Lab Med; 1986 Dec; 110(12):1160-3. PubMed ID: 3022672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.